Divis Laboratories Ltd | DIVI - Stammkapital

Aktienkurs
6,077.00
Täglich Wechseln
51.00 0.85%
Monatlich
-6.13%
Jährlich
4.07%
Q1 Prognose
5,976.17




Stammkapital Veränderung Datum
Alaunos Therapeutics USD 2.21M 131K 2025-09
Aurobindo Pharma INR 580.8M 2K 2025-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Lupin INR 456.76M 456.44M 2025-09
Moderna USD 391M 2M 2025-09
Organon & Co USD 259.98M 18K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12